Platelet Rich Plasma Versus Corticosteroids in Knee Osteoarthritis Pain

Ki vehet részt

• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Male or female, aged 21-80 years
• Radiographic diagnosis of Kellgren-Lawrence (KL) grade of II or III knee osteoarthritis
• Indicated for a knee injection to treat knee OA symptoms

Ki nem vehet részt

• Current or previous diagnosis of "chronic pain"
• Treatment with another investigational drug or other intervention for pain
• Current overlying skin infection
• Allergy to any potential ingredients or medications utilized in any of the two groups
• Diagnosis of Diabetes Mellitus
• Any condition(s) or diagnosis, both physical or psychological, or physical exam finding in the opinion of the investigator that would precludes participation
• Any injections into the target knee within three months
• Opioid tolerant at time of screening (for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid.)
• If female, pregnant or planning to be pregnant within the following 3 months or study duration